Facebook picto   picto linkdink   picto tiwter


May 12, 2020
EDAP announces exclusive worldwide distribution rights to EXACT Imaging's Micro-Ultrasound Technologies


EDAP announces exclusive worldwide distribution rights to EXACT Imaging's Micro-Ultrasound Technologies

EDAP TMS SA, the global leader in robotic energy based therapies, announced today that the company has signed an exclusive worldwide distribution agreement with Exact Imaging, a developer of high resolution micro-ultrasound imaging technologies. Under the terms of the agreement, EDAP will market Exact Imaging’s micro-ultrasound diagnostic devices alongside its Focal One high intensity focused ultrasound (HIFU) treatment solution. The combination of these technologies represents the most complete end-to-end solution, from diagnosis through treatment, available to urologists today.     

Marc Oczachowski, Chairman and Chief Executive Officer of EDAP, commented: “We are very excited to announce this exclusive worldwide partnership with Exact Imaging. Integrating their ExactVu diagnostic device with our range of innovative and state of the art product lines at a global distribution level will allow us to continue to drive growth in our distribution business, which has grown by more than 200% over the past five years. In addition to being a great stand-alone product and a unique ultrasound solution, clinical studies have reported a diagnostic accuracy similar to MRI in identifying prostate cancer. Further, a recently published study observed an improvement in diagnostic accuracy when ExactVu micro-ultrasound was added to MRI. ExactVu has a number of synergies with Focal One, and the combination of both makes EDAP the only company able to offer a complete solution from diagnostic to treatment for the focal management of prostate cancer. We are eager to commence this partnership and look forward to leveraging the combination of these two leading technologies to drive HIFU adoption and growth.”

Randy AuCoin, President and Chief Executive Officer of Exact Imaging, stated: “We are very excited to enter into this agreement with EDAP. EDAP’s position as a leader in the urology market, its HIFU technology, and its track record of innovation in providing minimally invasive therapy solutions to prostate cancer patients provide an excellent complement to Exact Imaging’s technology. In addition, EDAP’s network of subsidiary companies and distribution partners provide an exciting opportunity for Exact Imaging to reach new customers worldwide. We look forward to a long and mutually beneficial partnership.”